3.110TRY-2.81%Mkt Cap: 3.09B TRYP/E: —Last update: 2026-05-14
Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B0.30
P/S0.61
EV/EBITDA5.20
EV/Revenue1.41
EPS (TTM)-0.50
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-101.72%
FCF Margin-61.80%
Operating CF-378.48M TRY
CapEx (TTM)151.66M TRY
Net Debt/EBITDA2.96
Net Debt4.08B TRY
Technical
SMA 502.843 (+9.4%)
SMA 2003.006 (+3.5%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)109.21M
Avg Vol (10d)250.15M
Technical Indicators
RSI (14)46.0
MACD0.2162
MACD Signal0.2829
MACD Hist.-0.0668
BB Upper4.288 TRY
BB Middle3.384 TRY
BB Lower2.479 TRY
BB Width53.47%
ATR (14)0.2829 TRY
Vol Ratio (20d)2.23x
52W Range
2.25340% of range4.400
52W High4.400 TRY
52W Low2.253 TRY
Profitability
Gross Margin31.22%
EBITDA Margin27.08%
Profit Margin2.82%
Oper. Margin23.25%
ROE3.76%
ROA1.81%
Revenue Growth103.90%
Earnings Growth—
Balance Sheet
Debt/Equity0.86
Current Ratio0.99
Quick Ratio0.49
Book Value/Sh10.03 TRY
Cash/Share0.0440 TRY
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 TRY
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split640.8949:100
Split DateApr 27, 2026
Ownership
Shares Out.1.04B
Float422.42M
Insiders40.14%
Institutions15.14%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap3.09B TRY
Enterprise Value7.17B TRY
Revenue (TTM)5.09B TRY
Gross Profit801.53M TRY
Net Income (TTM)72.36M TRY
Revenue/Share4.377 TRY
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees709
Last Price3.110 TRY
CountryTR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—